Brain Diseases, Metabolic
"Brain Diseases, Metabolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.
MeSH Number(s)
C10.228.140.163
C18.452.132
Concept/Terms
Brain Diseases, Metabolic- Brain Diseases, Metabolic
- Brain Disease, Metabolic
- Metabolic Brain Disease
- Metabolic Disorders, Brain
- Brain Metabolic Disorder
- Brain Metabolic Disorders
- Metabolic Disorder, Brain
- Metabolic Encephalopathies
- Metabolic Brain Syndromes
- Brain Syndrome, Metabolic
- Encephalopathies, Metabolic
- Encephalopathy, Metabolic
- Metabolic Encephalopathy
- Metabolic Brain Syndrome
- Metabolic Brain Diseases
- Brain Disorders, Metabolic
- Brain Disorder, Metabolic
- Metabolic Brain Disorder
- Metabolic Brain Disorders
Brain Diseases, Metabolic, Acquired- Brain Diseases, Metabolic, Acquired
- Acquired Metabolic Encephalopathies
- Acquired Metabolic Encephalopathy
- Encephalopathies, Acquired Metabolic
- Encephalopathy, Acquired Metabolic
- Metabolic Encephalopathies, Acquired
- Metabolic Encephalopathy, Acquired
- Brain Disorders, Metabolic, Acquired
- Encephalopathy, Metabolic, Acquired
- Metabolic Brain Diseases, Acquired
- Metabolic Brain Syndrome, Acquired
- Metabolic Brain Syndromes, Acquired
- Acquired Metabolic Diseases, Brain
- Brain Syndrome, Metabolic, Acquired
Central Nervous System Metabolic Disorders- Central Nervous System Metabolic Disorders
- Metabolic Disorders, Central Nervous System
- Metabolic Disorders, CNS
- CNS Metabolic Disorders
- CNS Metabolic Disorder
- Metabolic Disorder, CNS
Below are MeSH descriptors whose meaning is more general than "Brain Diseases, Metabolic".
Below are MeSH descriptors whose meaning is more specific than "Brain Diseases, Metabolic".
This graph shows the total number of publications written about "Brain Diseases, Metabolic" by people in Harvard Catalyst Profiles by year, and whether "Brain Diseases, Metabolic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 3 | 1 | 4 |
2014 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 3 | 0 | 3 |
2018 | 0 | 1 | 1 |
2019 | 1 | 1 | 2 |
2022 | 1 | 1 | 2 |
Below are the most recent publications written about "Brain Diseases, Metabolic" by people in Profiles.
-
Hypoglycemic encephalopathy. QJM. 2022 07 09; 115(7):478-479.
-
Detection of IEMs by Mass Spectrometry Techniques in High-Risk Children: A Pilot Study. Indian J Pediatr. 2022 09; 89(9):885-893.
-
Standardizing genetic and metabolic consults for non-accidental trauma at a large pediatric academic center. Child Abuse Negl. 2022 03; 125:105480.
-
Prognostic Utility of Daily Changes in Glasgow Coma Scale and the Full Outline of Unresponsiveness Score Measurement in Patients with Metabolic Encephalopathy, Central Nervous System Infections and Stroke in Uganda. Neurocrit Care. 2021 12; 35(3):835-844.
-
Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. Proc Natl Acad Sci U S A. 2019 03 26; 116(13):6379-6384.
-
Cephalosporin neurotoxicity: An overlooked cause of toxic-metabolic encephalopathy. J Neurol Sci. 2019 03 15; 398:194-195.
-
Movement Disorders in Treatable Inborn Errors of Metabolism. Mov Disord. 2019 05; 34(5):598-613.
-
Isolated hyperammonemic encephalopathy in heart transplantation. J Heart Lung Transplant. 2018 03; 37(3):427-429.
-
Systemic Manifestations in Pyridox(am)ine 5'-Phosphate Oxidase Deficiency. Pediatr Neurol. 2017 Nov; 76:47-53.
-
Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity. Orphanet J Rare Dis. 2017 04 24; 12(1):77.